Jean-François GIRMENS
Jean-François GIRMENS
CHNO des Quinze-Vingts
Adresse e-mail validée de - Page d'accueil
Citée par
Citée par
Persistence of fundus fluorescence after use of indocyanine green for macular surgery
R Tadayoni, M Paques, JF Girmens, P Massin, A Gaudric
Ophthalmology 110 (3), 604-608, 2003
Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy
A Lecleire-Collet, I Audo, M Aout, JF Girmens, R Sofroni, A Erginay, ...
Investigative Ophthalmology & Visual Science 52 (6), 2861-2867, 2011
Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome
D Dossarps, AM Bron, P Koehrer, LS Aho-Glélé, C Creuzot-Garcher, ...
American journal of ophthalmology 160 (1), 17-25. e1, 2015
Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset
NJ Newman, P Yu-Wai-Man, V Carelli, ML Moster, V Biousse, ...
Ophthalmology 128 (5), 649-660, 2021
Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than …
JF Girmens, A Erginay, P Massin, P Scigalla, A Gaudric, S Richard
American journal of ophthalmology 136 (1), 194-196, 2003
Safety of rAAV2/2-ND4 gene therapy for Leber hereditary optic neuropathy
C Vignal, S Uretsky, S Fitoussi, A Galy, L Blouin, JF Girmens, S Bidot, ...
Ophthalmology 125 (6), 945-947, 2018
Human cataract lens membrane at subnanometer resolution
N Buzhynskyy, JF Girmens, W Faigle, S Scheuring
Journal of molecular biology 374 (1), 162-169, 2007
The 10q26 Risk Haplotype of Age-Related Macular Degeneration Aggravates Subretinal Inflammation by Impairing Monocyte Elimination
F Beguier, M Housset, C Roubeix, S Augustin, Y Zagar, C Nous, T Mathis, ...
Immunity 53 (2), 429-441. e8, 2020
Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials
L Kodjikian, E Decullier, EH Souied, JF Girmens, EE Durand, FR Chapuis, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 252 (10), 1529-1537, 2014
Intravitreal gene therapy vs. natural history in patients with Leber hereditary optic neuropathy carrying the m. 11778G> A ND4 mutation: systematic review and indirect comparison
NJ Newman, P Yu-Wai-Man, V Carelli, V Biousse, ML Moster, ...
Frontiers in neurology, 580, 2021
Imaging of macroaneurysms occurring during retinal vein occlusion and diabetic retinopathy by indocyanine green angiography and high resolution optical coherence tomography
A Bourhis, JF Girmens, S Boni, F Pecha, C Favard, JA Sahel, M Paques
Graefe's Archive for Clinical and Experimental Ophthalmology 248 (2), 161-166, 2010
Dry age-related macular degeneration: A currently unmet clinical need
JF Girmens, JA Sahel, K Marazova
Intractable Rare Dis Res 1, 103-114, 2012
Safety of intravitreal gene therapy for treatment of subjects with Leber hereditary optic neuropathy due to mutations in the mitochondrial ND4 gene: the REVEAL study
C Vignal-Clermont, JF Girmens, I Audo, SM Said, MH Errera, L Plaine, ...
BioDrugs 35 (2), 201-214, 2021
Indocyanine-green-guided targeted laser photocoagulation of capillary macroaneurysms in macular oedema: a pilot study
M Paques, E Philippakis, C Bonnet, S Falah, S Ayello-Scheer, ...
British Journal of Ophthalmology 101 (2), 170-174, 2017
Odysight: a mobile medical application designed for remote monitoring—a prospective study comparison with standard clinical eye tests
J Brucker, V Bhatia, JA Sahel, JF Girmens, S Mohand-Saïd
Ophthalmology and therapy 8, 461-476, 2019
Efficacité et tolérance de l′ huile de silicone lourde dans la chirurgie du décollement de rétine
S Scheer, S Boni, PO Barale, A Bourhis, S Bonnel, E Tuil, JF Girmens, ...
Journal français d'ophtalmologie 29 (2), 129-135, 2006
Occlusions veineuses rétiniennes
A Pierru, JF Girmens, E Héron, M Paques
Journal Français d'Ophtalmologie 40 (8), 696-705, 2017
Malformation of junctional microdomains in cataract lens membranes from a type II diabetes patient
S Mangenot, N Buzhynskyy, JF Girmens, S Scheuring
Pflügers Archiv European Journal of Physiology 457 (6), 1265-1274, 2009
Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study
P Massin, C Creuzot-Garcher, L Kodjikian, JF Girmens, C Delcourt, ...
Ophthalmic research 62 (2), 101-110, 2019
Venous nicking without arteriovenous contact: the role of the arteriolar microenvironment in arteriovenous nickings
M Paques, A Brolly, J Benesty, N Lermé, E Koch, F Rossant, I Bloch, ...
JAMA ophthalmology 133 (8), 947-950, 2015
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20